AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)
AAPL 170.33 +0.29 (+0.17%)MSFT 108.2 +0.55 (+0.51%)FB 130.65 -2.52 (-1.89%)ZNGA 3.95 +0.07 (+1.68%)NVDA 133.37 -0.29 (-0.22%)WBA 68.22 +0.16 (+0.24%)GOOG 1029.8 -7.78 (-0.75%)PIH 4.14 +0.25 (+6.43%)

Balance Sheet ANIK Quote Anika Thera

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 111 104 133
ShortTermInvest 28 20 24
Cash 138 125 157
AccountReceivab 22 28 24
Inventories 15 16 22
DeferredIncomeT 0 0 0
OtherCurrentAss 0 0 0
TotalCurrentAss 176 170 206
PPE 65 79 76
AccumulatedDepr -25 -27 -20
NetPPE 40 52 56
EquityAndOtherI 0 0 0
Goodwill 7 7 8
IntangibleAsset 12 10 11
OtherLTAssets 0 0 1
TotalNonCurrent 59 70 76
TotalAssets 236 240 283
ShortTermDebt 0 0 0
AccountsPayable 8 2 7
TaxesPayable 4 0 0
AccruedLiabilit 5 6 6
DeferredRevenue 0 0 0
OtherCurrentLia 0 0 0
TotalCurrentLia 17 9 13
Debt 0 0 0
DeferredTaxesLi 7 7 5
DeferredRevenue 0 0 0
OtherLTLiabilit 1 2 1
TotalNonCurrent 8 9 6
TotalLiabilitie 25 17 19
CommonStock 0 0 0
AdditionalPaidI 82 62 69
RetainedEarning 136 168 200
AccumulatedOthe -7 -7 -5
TotalStockholde 211 223 263
TotalLiabilitie 236 240 283
Anika Therapeutics Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Anika Therapeutics Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.